Clinical Trials on Endometrial Bladder Disease in Norway
Total 5973 results
-
Ullevaal University HospitalCompletedEndometrial Cancer | Endometrial PolypNorway
-
Nordic Society of Gynaecological Oncology - Clinical...Completed
-
The Hospital of VestfoldSouth-Eastern Norway Regional Health AuthorityCompletedOveractive BladderNorway
-
University of OsloCompletedCervical Cancer | Ovarian Cancer | Endometrial CancerNorway
-
University Hospital of North NorwayNorwegian Cancer Society; Helse NordCompletedEndometrial HyperplasiaNorway
-
Norwegian School of Sport SciencesNorwegian Foundation for Health and Rehabilitation; The Norwegian Women´s Public...CompletedCystocele | Uterine Prolapse | Rectocele | Bladder DiseasesNorway
-
Haukeland University HospitalRecruitingEndometrial CancerNorway, Netherlands, Poland
-
University of OsloLund University; University of Copenhagen; University of BergenCompletedAcute Cystitis (Excl in Pregnancy)Norway
-
Jørgen Bjerggaard JensenNovo Nordisk A/S; University of AarhusRecruitingNon-muscle Invasive Bladder CancerDenmark, Norway, Latvia
-
National Cancer Institute (NCI)Completed
-
Oslo University HospitalSunnaas Rehabilitation HospitalCompletedUrinary Bladder, Overactive | Spinal Cord InjuriesNorway
-
Sunnaas Rehabilitation HospitalUniversity of Oslo; SINTEF MiNaLabCompletedCystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction (PEPRE2)Spinal Cord Injuries | Urinary Bladder, NeurogenicNorway
-
Coloplast A/SCompletedNeurogenic Bladder Dysfunction NosDenmark, France, Germany, Norway, Sweden
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompletedRadiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial (RICH-ART)Cystitis, Radio InducedSweden, Norway, Denmark, Finland
-
Sorlandet Hospital HFUppsala University; University of AgderRecruitingCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Gynecologic NeoplasmNorway
-
PfizerCompletedOveractive BladderCzech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
-
Juniper Pharmaceuticals, Inc.CompletedEndometrial BiopsyUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...European Organisation for Research and Treatment of Cancer - EORTCCompletedEndometrial CancerFrance, Norway, Belgium, Spain, Netherlands, Italy, United Kingdom, Ireland, Poland, Portugal, South Africa
-
University of BergenNorwegian Cancer Society; Helse-Bergen HFUnknownNeoplasm Metastasis | Endometrial NeoplasmsBelgium, Norway, Sweden
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Dedifferentiated Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Endometrial Adenocarcinoma | Recurrent Endometrial... and other conditionsUnited States, Korea, Republic of, Canada, Puerto Rico, Japan
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); Gynecologic Oncology GroupCompletedEndometrial CancerUnited States, Norway
-
Memorial Sloan Kettering Cancer CenterRecruitingEndometrial Cancer | Endometrioid Adenocarcinoma | Endometrial Cancer Stage IUnited States, Czechia, Italy, Norway
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States, Norway
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Norway, Canada, Australia, Japan
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
AllerganTerminatedUrinary Incontinence | Urinary Bladder | OveractiveUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada, Norway, United Kingdom, Australia
-
Nordic Society of Gynaecological Oncology - Clinical...ARCAGY/ GINECO GROUP; Belgian Gynaecological Oncology Group; North Eastern German...CompletedEndometrial CancerFrance, Belgium, Germany, Norway, Finland, Sweden, Denmark
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedBladder Urothelial Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States, Canada
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
PfizerCompletedOveractive Bladder SyndromeUnited States, Canada, Greece, Brazil, Korea, Republic of, Singapore, Poland, India, Norway, Slovakia, Spain, Belgium, Philippines, Netherlands, Sweden, Thailand, Malaysia, Germany, Colombia
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditionsUnited States, Canada
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingBladder Urothelial Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
AEterna ZentarisCompletedEndometrial CancerUnited States, Spain, Canada, Ireland, Norway, Austria, Denmark, Israel, United Kingdom, Belgium, Finland, Romania, Czechia, Italy, Poland, Germany, Netherlands, Belarus, Bosnia and Herzegovina, Bulgaria, Russian Federation, Ukraine
-
PfizerCompletedOveractive BladderUnited States
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
PfizerCompleted
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
R-PharmTerminatedEndometrial CancerBrazil, Czech Republic, Italy, Mexico, Russian Federation, Sweden, United Kingdom, United States, Spain, Canada, Denmark, France, Peru, Belgium, Hungary, Norway, Argentina, Australia, Greece
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more